U.S. Gynecological Devices Market - Databook 2025 to 2034

The U.S. gynecological devices market size surpassed USD 3.85 billion in 2024 and is predicted to reach around USD 8.53 billion by 2034, registering a CAGR of 8.28% from 2025 to 2034.

Highlights of the U.S. Gynecological Devices Market

• By product, the surgical devices segment was dominant in the U.S. gynecological devices market in 2024.
• By product, the diagnostic imaging systems segment is expected to experience the highest growth rate in the market between 2025 and 2034.
• By end use, the hospitals and clinics segment accounted for a considerable share of the U.S. gynecological devices market in 2024.
• By end use, the ambulatory surgical centers (ASCs) are set to experience the fastest rate of market growth from 2025 to 2034.

Industry Valuation and Growth Rate Projection

Gynecological devices refer to a globalized network of medical instruments and technology devised for diagnosing, treating, and managing female reproductive system disorders. This includes diagnosing and treating conditions like pelvic pain, ovarian cysts, and endometriosis. Gynecologists also perform routine preventive care like breast exams and Pap smears. The U.S. gynecological devices market growth is driven by the use of technically advanced products, a rise in initiatives promoting routine checkups, and the rising prevalence of gynecological disorders.

The U.S. gynecological devices market has a wide range of applications, including its use for applying silicone bands to fallopian tubes in laparoscopic tubal ligation. Clinical ultrasound has extensive applications ranging from routine parenteral screenings to complex gynecological evaluations, underscoring its integral role in improving patient care and clinical outcomes. Gynecology comprises both medicine as well as surgical fields.

Market Trends

Growing awareness of women’s health: Women’s health education is important for empowering women to make informed choices and achieve overall wellness throughout their lives. Women’s health can be improved by escaping the monotony of daily routine, improving diet, quitting smoking, scheduling an annual well-woman exam, making sleep a top priority, and being physically active more often.

Increase in prevalence of gynecological disorders: Stress, rest deficiency, and an insufficient diet are the main causes of the increase in gynecological disorders. Stress and anxiety causing hormonal imbalance which severely affect women’s physical health like delayed menstrual cycle, menstrual cycle disorders, changes in the microbiological environment, and vagina’s pH which facilitates the gynecological diseases development.

Restraints

Adoption of alternate therapies: Alternative therapies are considered to be treatments for common pregnancy issues which not involve traditional medications. These can include meditation, massage, and natural products to relieve annoying symptoms of pregnancy like backache and nausea. These factors can slow down the growth of the U.S. gynecological devices market.

High cost of gynecological procedures: The high costs in gynecology can be attributed to many factors. These include the cost of innovative diagnostic devices like MRI scanners and ultrasound machines, expensive specialized treatments, and surgical procedures. The requirement of ongoing monitoring and follow-up further adds to the overall costs. Specifically, in vitro fertilization (IVF) fertility treatments are expensive because of the complexity and multiple stages involved in the process.

Opportunity

Increasing investment in research and development: R&D drives innovation, facilitates market expansion, improves competitive advantage, and contributes to sustainable development. Investing in research and development (R&D) directly contributes to sustainable development. R&D represents the activities that companies undertake to innovate and introduce new products and services or to enhance their existing offerings. R&D allows a company to stay ahead of its competition by catering to new wants or needs in the market.

Recent Developments in the U.S. Gynecological Devices Market

• In September 2024, a new 4K camera head, CH-S700-08-LB, for endoscopic urology and gynecology procedures was launched by Olympus. This procedure helps to advance urological care and enhance patient outcomes by providing improved visibility during surgical procedures.
• In May 2023, an Advanced Gynecology Institute (AGI), designed to offer multidisciplinary healthcare solutions to women of all ages, was launched by the flagship facility of Burjeel Holdings, Burjeel Medical City.